ORBIMED ADVISORS LLC Insider Trading $ALEC Alector, Inc.
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in GLAUKOS Corp ($GKOS) and Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and in ACCELERON PHARMA INC ($XLRN) and Director in ProNAi Therapeutics Inc ($DNAI) and 10% Owner in AVEDRO INC ($AVDR) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ARPO) and Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in SI-BONE, Inc. ($SIBN) and Director in Xtant Medical Holdings, Inc. ($XTNT) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and Director in Otonomy, Inc. ($OTIC) and 10% Owner in Arsanis, Inc. ($ASNS) and 10% Owner in Principia Biopharma Inc. ($PRNB) and Director in Acutus Medical, Inc. ($AFIB) and Director in SYNLOGIC, INC. ($MIRN) and 10% Owner in NeuroPace Inc ($NPCE) and 10% Owner in GRAYBUG VISION, INC. ($GRAY) and 10% Owner in Sientra, Inc. ($SIEN) and 10% Owner in TELA Bio, Inc. ($TELA) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in Dimension Therapeutics, Inc. ($DMTX) and 10% Owner in Guardant Health, Inc. ($GH) and 10% Owner in ViewRay, Inc. ($VRAY) and Director in ViewRay, Inc. ($VRAY) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and 10% Owner in Inspire Medical Systems, Inc. ($INSP) and Director in Inspire Medical Systems, Inc. ($INSP) and Director in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and Director in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in Intellia Therapeutics, Inc. ($NTLA) and 10% Owner in Alector, Inc. ($ALEC) and Director in Alector, Inc. ($ALEC) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in NextCure, Inc. ($NXTC) and Director in LogicBio Therapeutics, Inc. ($LOGC) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in IMARA Inc. ($IMRA) and Director in Keros Therapeutics, Inc. ($KROS) and Director in Prelude Therapeutics Inc ($PRLD) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in resTORbio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and Director in Edgewise Therapeutics, Inc. ($EWTX) and Director in 89bio, Inc. ($ETNB) and Director in Arcutis Biotherapeutics, Inc. ($ARQT) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Fusion Pharmaceuticals Inc. ($FUSN) and Director in Terns Pharmaceuticals, Inc. ($TERN) and Director in Ikena Oncology, Inc. ($IKNA).
ORBIMED ADVISORS LLC in Alector, Inc.
Trading Symbol: ALECIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: 10% Owner, Director
Holdings: 6,002,771 shares
Latest Transaction: Apr 16 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in Alector, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ETNB, XLRN, AFIB, ADAP, TORC, AGLE, ARPO, ALEC, ALPN, ARQT, ARMO, BOLD, AVDR, CNST, CRVS, CTIC, DBTX, DMTX, EWTX, FUSN, GKOS, GRAY, GH, IKNA, IMRA, INSP, NTLA, ICPT, KALA, KROS, KNTE, LOGC, LOXO, NPCE, NXTC, ORIC, OTIC, PIRS, PMVP, PRLD, PRVL, PRNB, RLYP, RPTX, RPBIF, RYTM, SCPH, SELB, SIBN, SIEN, SRRA, SBTX, ROKA, SWTX, STDY, SYBX, THOR, TELA, TERN, TCDA, TPTX, VRAY, ASNS, XTNT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.53 | 15,086 | 354,974 | 1,906,718 | 1.9 M to 1.9 M (-0.78 %) |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.53 | 47,097 | 1,108,192 | 5,955,674 | 6 M to 6 M (-0.78 %) |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.52 | 5,636 | 132,559 | 1,921,804 | 1.9 M to 1.9 M (-0.29 %) |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.52 | 17,595 | 413,834 | 6,002,771 | 6 M to 6 M (-0.29 %) |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.53 | 15,086 | 354,974 | 1,906,718 | 1.9 M to 1.9 M (-0.78 %) |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.53 | 47,097 | 1,108,192 | 5,955,674 | 6 M to 6 M (-0.78 %) |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.52 | 5,636 | 132,559 | 1,921,804 | 1.9 M to 1.9 M (-0.29 %) |
Apr 16 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.52 | 17,595 | 413,834 | 6,002,771 | 6 M to 6 M (-0.29 %) |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.79 | 69,893 | 1,662,754 | 1,927,440 | 2 M to 1.9 M (-3.50 %) |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.79 | 218,208 | 5,191,168 | 6,020,366 | 6.2 M to 6 M (-3.50 %) |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.65 | 20,041 | 473,970 | 1,997,333 | 2 M to 2 M (-0.99 %) |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.65 | 62,573 | 1,479,851 | 6,238,574 | 6.3 M to 6.2 M (-0.99 %) |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.10 | 2,224 | 51,374 | 2,017,374 | 2 M to 2 M (-0.11 %) |
Apr 09 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 23.10 | 6,946 | 160,453 | 6,301,147 | 6.3 M to 6.3 M (-0.11 %) |
Apr 02 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 24.50 | 60,645 | 1,485,803 | 2,019,598 | 2.1 M to 2 M (-2.92 %) |
Apr 02 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 24.50 | 189,355 | 4,639,198 | 6,308,093 | 6.5 M to 6.3 M (-2.91 %) |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 24.66 | 13,684 | 337,447 | 2,080,243 | 2.1 M to 2.1 M (-0.65 %) |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 24.66 | 42,727 | 1,053,648 | 6,497,448 | 6.5 M to 6.5 M (-0.65 %) |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 24.45 | 16,409 | 401,200 | 2,093,927 | 2.1 M to 2.1 M (-0.78 %) |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 24.45 | 51,235 | 1,252,696 | 6,540,175 | 6.6 M to 6.5 M (-0.78 %) |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 26.05 | 3,541 | 92,243 | 2,110,336 | 2.1 M to 2.1 M (-0.17 %) |
Mar 25 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 26.05 | 11,057 | 288,035 | 6,591,410 | 6.6 M to 6.6 M (-0.17 %) |
Mar 04 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 26.00 | 38,808 | 1,009,008 | 0 | 38.8 K to 0 (-100.00 %) |
Mar 04 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 26.00 | 445,086 | 11,572,236 | 2,113,877 | 2.6 M to 2.1 M (-17.39 %) |
Mar 04 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 26.00 | 1,390,309 | 36,148,034 | 6,602,467 | 8 M to 6.6 M (-17.39 %) |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.50 | 1,392 | 27,144 | 38,808 | 40.2 K to 38.8 K (-3.46 %) |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.50 | 91,818 | 1,790,451 | 2,558,963 | 2.7 M to 2.6 M (-3.46 %) |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.50 | 286,787 | 5,592,347 | 7,992,776 | 8.3 M to 8 M (-3.46 %) |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.50 | 1,392 | 27,144 | 38,808 | 40.2 K to 38.8 K (-3.46 %) |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.50 | 91,818 | 1,790,451 | 2,558,963 | 2.7 M to 2.6 M (-3.46 %) |
Jan 13 2020 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.50 | 286,787 | 5,592,347 | 7,992,776 | 8.3 M to 8 M (-3.46 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 18.60 | 1,200 | 22,320 | 40,200 | 41.4 K to 40.2 K (-2.90 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 18.60 | 2,325 | 43,245 | 2,650,781 | 2.7 M to 2.7 M (-0.09 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 18.60 | 7,275 | 135,315 | 8,279,563 | 8.3 M to 8.3 M (-0.09 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.59 | 8,000 | 156,720 | 41,400 | 49.4 K to 41.4 K (-16.19 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.59 | 15,476 | 303,175 | 2,653,106 | 2.7 M to 2.7 M (-0.58 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.59 | 48,324 | 946,667 | 8,286,838 | 8.3 M to 8.3 M (-0.58 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.82 | 10,400 | 206,128 | 49,400 | 59.8 K to 49.4 K (-17.39 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.82 | 20,350 | 403,337 | 2,668,582 | 2.7 M to 2.7 M (-0.76 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.82 | 63,535 | 1,259,264 | 8,335,162 | 8.4 M to 8.3 M (-0.76 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.66 | 37,900 | 745,114 | 59,800 | 97.7 K to 59.8 K (-38.79 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.66 | 73,879 | 1,452,461 | 2,688,932 | 2.8 M to 2.7 M (-2.67 %) |
Dec 26 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 19.66 | 230,721 | 4,535,975 | 8,398,697 | 8.6 M to 8.4 M (-2.67 %) |
Dec 19 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 18.52 | 105,500 | 1,953,860 | 97,700 | 203.2 K to 97.7 K (-51.92 %) |
Dec 19 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 18.52 | 205,793 | 3,811,286 | 2,762,811 | 3 M to 2.8 M (-6.93 %) |
Dec 19 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 18.52 | 642,807 | 11,904,786 | 8,629,418 | 9.3 M to 8.6 M (-6.93 %) |
Aug 09 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 17.90 | 157,636 | 2,821,684 | 2,968,604 | 3.1 M to 3 M (-5.04 %) |
Aug 09 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 17.90 | 492,364 | 8,813,316 | 9,272,225 | 9.8 M to 9.3 M (-5.04 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 85,295 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 266,437 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 234,601 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,012,282 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 528,510 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,280,479 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 470,374 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,029,626 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 992,437 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 4,282,288 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 94,075 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 405,925 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 19.00 | 203,200 | 3,860,800 | 203,200 | 0 to 203.2 K |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 19.00 | 50,561 | 960,659 | 2,455,853 | 2.4 M to 2.5 M (+2.10 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 85,295 | 0 | 2,405,292 | 2.3 M to 2.4 M (+3.68 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 234,601 | 0 | 2,319,997 | 2.1 M to 2.3 M (+11.25 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 528,510 | 0 | 2,085,396 | 1.6 M to 2.1 M (+33.95 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 470,374 | 0 | 1,556,886 | 1.1 M to 1.6 M (+43.29 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 992,437 | 0 | 1,086,512 | 94.1 K to 1.1 M (+1,054.94 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 94,075 | 0 | 94,075 | 0 to 94.1 K |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 19.00 | 157,939 | 3,000,841 | 10,434,976 | 10.3 M to 10.4 M (+1.54 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 266,437 | 0 | 10,277,037 | 10 M to 10.3 M (+2.66 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,012,282 | 0 | 10,010,600 | 9 M to 10 M (+11.25 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 2,280,479 | 0 | 8,998,318 | 6.7 M to 9 M (+33.95 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 2,029,626 | 0 | 6,717,839 | 4.7 M to 6.7 M (+43.29 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 4,282,288 | 0 | 4,688,213 | 405.9 K to 4.7 M (+1,054.95 %) |
Feb 11 2019 | ALEC | Alector, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 405,925 | 0 | 405,925 | 0 to 405.9 K |
Page: 1